John Huang Selected Research

John Huang Research Topics

Disease

15	Neoplasms (Cancer) 11/2021 - 06/2007
8	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 08/2009
4	Neoplasm Metastasis (Metastasis) 08/2021 - 07/2012
4	Carcinogenesis 06/2017 - 08/2009
4	Colonic Neoplasms (Colon Cancer) 08/2015 - 08/2009
2	Rectal Neoplasms (Rectal Cancer) 03/2021 - 11/2017
2	Melanoma (Melanoma, Malignant) 12/2014 - 01/2014
1	Appendicitis 01/2022
1	Triple Negative Breast Neoplasms 11/2021
1	Adenocarcinoma of Lung 11/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2020
1	Arthritis (Polyarthritis) 11/2020
1	Cancer Pain 11/2020
1	Dentofacial Deformities 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 12/2017
1	Pathologic Complete Response 11/2017
1	Liver Failure 11/2017
1	Delirium 09/2017
1	Glaucoma 02/2016
1	Lymphatic Metastasis 08/2015
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Hemangioma (Angioma) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 12/2011
1	Neuroblastoma 09/2011
1	Refractive Errors (Refractive Error) 02/2011
1	Myopia 02/2011
1	Astigmatism 02/2011
1	Intestinal Failure 12/2010
1	Cholelithiasis 08/2009
1	Cholangitis 08/2009
1	Gallstones (Gallstone) 08/2009
1	Pancreatitis 08/2009
1	Acute Cholecystitis 08/2009

Drug/Important Bio-Agent (IBA)

5	MucinsIBA 06/2017 - 10/2007
4	Messenger RNA (mRNA)IBA 03/2015 - 08/2009
3	Polysaccharides (Glycans)IBA 11/2021 - 04/2014
3	EnzymesIBA 06/2017 - 12/2011
3	IntegrinsIBA 06/2014 - 06/2007
3	Tumor Viral Antigens (Large T Antigen)IBA 04/2014 - 01/2013
2	N 30IBA 08/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 12/2011
2	NestinIBA 12/2014 - 01/2014
2	poly-N-acetyllactosamineIBA 06/2014 - 04/2013
1	RamucirumabIBA 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	Docetaxel (Taxotere)FDA Link 11/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021
1	HydrogelsIBA 11/2021
1	EphrinsIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	EphA1 Receptor (Eph Receptor)IBA 01/2020
1	CTLA-4 AntigenIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Serine Proteases (Serine Protease)IBA 01/2019
1	AntigensIBA 01/2019
1	ManganeseIBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 12/2017
1	Methotrexate (Mexate)FDA LinkGeneric 12/2017
1	Cetuximab (Erbitux)FDA Link 11/2017
1	Bevacizumab (Avastin)FDA Link 11/2017
1	dorzolamide (Trusopt)FDA LinkGeneric 02/2016
1	Timolol (Blocadren)FDA LinkGeneric 02/2016
1	Thomsen-Friedenreich antigenIBA 03/2015
1	CateninsIBA 03/2015
1	Biological ProductsIBA 12/2014
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2014
1	Matrix Metalloproteinases (MMPs)IBA 12/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2014
1	N- acetylgalactosaminyl- 1- 4- N- acetylglucosamineIBA 06/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2014
1	Molecular Chaperones (Chaperone, Molecular)IBA 02/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2014
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2014
1	Laminin (Merosin)IBA 01/2014
1	laminin AIBA 01/2014
1	MitogensIBA 01/2014
1	MicroRNAs (MicroRNA)IBA 07/2012
1	Death-Associated Protein KinasesIBA 07/2012
1	ErbB Receptors (EGF Receptor)IBA 12/2011

Therapy/Procedure

2	Neoadjuvant Therapy 03/2021 - 11/2017
2	Therapeutics 11/2020 - 11/2017
1	Drug Therapy (Chemotherapy) 10/2022
1	Salvage Therapy 10/2022
1	Appendectomy 01/2022
1	Radiofrequency Ablation 08/2021
1	Hepatectomy 08/2021
1	Metastasectomy 08/2021
1	Adjuvant Chemotherapy 03/2021
1	Immunotherapy 01/2019
1	Length of Stay 09/2017
1	Lymph Node Excision (Lymph Node Dissection) 08/2015
1	Operative Surgical Procedures 08/2015
1	Laser-Assisted Subepithelial Keratectomy (LASEK) 02/2011
1	Penetrating Keratoplasty 02/2011
1	Photorefractive Keratectomy 02/2011
1	Transplantation 12/2010
1	Cholecystectomy 08/2009